Churchill Capital XIII completes $414M SPAC IPO

Q: What did Churchill Capital Corp XIII (XIIIU) raise in its IPO?

Churchill Capital Corp XIII raised $414,000,000 in gross proceeds from an upsized IPO of 41,400,000 units at $10.00 per unit, including full exercise of the underwriter’s over-allotment option.

Q: How are the Churchill Capital Corp XIII (XIIIU) IPO funds held?

A total of $414,000,000 was placed in a U.S.-based trust account, combining $411,000,000 of IPO net proceeds and $1,500,000 from private placements, generally locked until a business combination or shareholder redemptions.

Q: What private placement did Churchill Capital Corp XIII (XIIIU) complete?

Simultaneously with the IPO, the company sold 350,000 Private Placement Units to its sponsor at $10.00 per unit, generating $3,500,000 in gross proceeds with no underwriting discounts or commissions paid.

Q: How long does Churchill Capital Corp XIII (XIIIU) have to complete a business combination?

The company generally has 24 months from the IPO closing to complete an initial business combination, extendable to 27 months if it signs a qualifying transaction agreement within the initial 24-month period.

Q: Who joined the Churchill Capital Corp XIII (XIIIU) board after the IPO?

Effective July 31, 2026, William Sherman joined the board, became interim chair of the Audit Committee, and chair of the Compensation Committee, underpinned by indemnification agreements with directors and executive officers.

Churchill Capital Corp XIII, a Cayman Islands SPAC, completed its upsized initial public offering of 41,400,000 units at $10.00 per unit, including the full exercise of the underwriter’s over-allotment option, generating $414,000,000 in gross proceeds.

Filing Impact

(Very High)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Churchill Capital Corp XIII, a Cayman Islands SPAC, completed its upsized initial public offering of 41,400,000 units at $10.00 per unit, including the full exercise of the underwriter’s over-allotment option, generating $414,000,000 in gross proceeds. Each unit includes one Class A ordinary share and one-tenth of one redeemable warrant, with each whole warrant exercisable at $11.50 per share.

The company also sold 350,000 Private Placement Units to its sponsor for $3,500,000. A total of $414,000,000, consisting of $411,000,000 of IPO net proceeds (including up to $15,490,000 of deferred underwriting discount) and $1,500,000 of private placement proceeds, was deposited into a U.S.-based trust account. These funds remain in trust until a business combination or required redemptions, generally within 24 months of the IPO closing (extendable to 27 months under specified conditions). The company adopted amended and restated charter documents and appointed William Sherman to its board and key committees, while entering into indemnification agreements with directors and officers.

Insights

Analyzing...

8-K Event Classification

6 items: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

6 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 3.02 Unregistered Sales of Equity Securities Securities

The company sold equity securities in a private placement or other unregistered transaction.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance

The company amended its charter documents, bylaws, or changed its fiscal year.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

IPO units sold: 41,400,000 units IPO price per unit: $10.00 per unit IPO gross proceeds: $414,000,000 +5 more

8 metrics

IPO units sold 41,400,000 units Upsized initial public offering including 5,400,000 over-allotment units

IPO price per unit $10.00 per unit Pricing of Churchill Capital Corp XIII’s units in the IPO

IPO gross proceeds $414,000,000 Total gross proceeds from the sale of 41,400,000 units

Private Placement Units 350,000 units Units sold to the sponsor at $10.00 per Private Placement Unit

Private placement proceeds $3,500,000 Gross proceeds from the sale of 350,000 Private Placement Units

Trust account funding $414,000,000 Amount placed in U.S.-based trust from IPO and private placement proceeds

Underwriter’s deferred discount $15,490,000 Portion of IPO net proceeds allocated as potential deferred underwriting discount

Business combination window 24–27 months Time from IPO closing to complete an initial business combination

Key Terms

over-allotment option, trust account, deferred discount, Private Placement Units, +1 more

5 terms

over-allotment option financial

"including 5,400,000 Units issued pursuant to the full exercise of the underwriter’s over-allotment option"

An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.

trust account financial

"was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company"

A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.

deferred discount financial

"which amount includes up to $15,490,000 of the underwriter’s deferred discount"

Private Placement Units financial

"completed the private sale of an aggregate of 350,000 units (the “Private Placement Units”) to the Sponsor"

Amended and Restated Memorandum and Articles of Association regulatory

"filed its Amended and Restated Memorandum and Articles of Association"

A document that replaces and combines a company’s core governing papers into a single, updated set of rules spelling out the company’s purpose, share structure, voting rights and how decisions are made. Think of it as rewriting and consolidating a household’s rulebook so everyone knows who controls what and how major choices are handled. Investors watch these changes because they can alter ownership rights, governance, dividend policy and takeover protections, affecting value and control.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Churchill Capital Corp XIII (XIIIU) raise in its IPO?

Churchill Capital Corp XIII raised $414,000,000 in gross proceeds from an upsized IPO of 41,400,000 units at $10.00 per unit, including full exercise of the underwriter’s over-allotment option.

How are the Churchill Capital Corp XIII (XIIIU) IPO funds held?

A total of $414,000,000 was placed in a U.S.-based trust account, combining $411,000,000 of IPO net proceeds and $1,500,000 from private placements, generally locked until a business combination or shareholder redemptions.

What are the terms of Churchill Capital Corp XIII (XIIIU) units and warrants?

Each unit includes one Class A ordinary share and one-tenth of one redeemable warrant; each whole warrant entitles holders to buy one Class A share at an exercise price of $11.50 per share.

What private placement did Churchill Capital Corp XIII (XIIIU) complete?

Simultaneously with the IPO, the company sold 350,000 Private Placement Units to its sponsor at $10.00 per unit, generating $3,500,000 in gross proceeds with no underwriting discounts or commissions paid.

How long does Churchill Capital Corp XIII (XIIIU) have to complete a business combination?

The company generally has 24 months from the IPO closing to complete an initial business combination, extendable to 27 months if it signs a qualifying transaction agreement within the initial 24-month period.

Who joined the Churchill Capital Corp XIII (XIIIU) board after the IPO?

Effective July 31, 2026, William Sherman joined the board, became interim chair of the Audit Committee, and chair of the Compensation Committee, underpinned by indemnification agreements with directors and executive officers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/12/2026 - 07:07 PM Accepted by SEC EDGAR 08/03/2026 - 04:10 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 30, 2026

CHURCHILL CAPITAL CORP XIII

(Exact name of registrant as specified in its charter)

Cayman Islands

001-43428

98-1918594

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

640 Fifth Avenue, 14th Floor

New York, NY 10019

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (212) 380-7500

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-tenth of one redeemable warrant	XIIIU	The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share	XIII	The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share	XIIIW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

On August 3, 2026, Churchill Capital Corp XIII (the “Company”) consummated its initial public offering (“IPO”) of 41,400,000 units (the “Units”), including 5,400,000 Units issued pursuant to the full exercise of the underwriter’s over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-tenth of one redeemable warrant of the Company (each, a “Warrant”), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $414,000,000.

In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s registration statement on Form S-1 (File No. 333-297472) for the IPO, originally filed with the U.S. Securities and Exchange Commission on July 15, 2026, as amended (and together with the registration statement on Form S-1MEF (File No. 333-297850), filed with the Commission on July 30, 2026, the “Registration Statement”):

●

An Underwriting Agreement, dated July 30, 2026, by and between the Company and Citigroup Global Markets Inc., as the underwriter, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.

●

A Public Warrant Agreement, dated July 30, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.

●

A Private Warrant Agreement, dated July 30, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.2 hereto and incorporated herein by reference.

●

An Investment Management Trust Agreement, dated July 30, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.

●

A Registration Rights Agreement, dated July 30, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.

●

A Private Placement Units Purchase Agreement, dated July 30, 2026 (the “Private Placement Units Purchase Agreement”), by and between the Company and the Company’s sponsor, Churchill Sponsor XIII LLC (the “Sponsor”), a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.

●

A Letter Agreement, dated July 30, 2026, by and among the Company, its officers, its directors and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.

●

An Administrative Support Agreement, dated July 30, 2026, by and between the Company and an affiliate of the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference.

●

Indemnification Agreements, dated July 30, 2026, by and among the Company and each director and officer of the Company, a form of which is attached as Exhibit 10.6 hereto and incorporated herein by reference.

Item 3.02. Unregistered Sales of Equity Securities.

Simultaneously with the closing of the IPO, pursuant to the Private Placement Units Purchase Agreement, the Company completed the private sale of an aggregate of 350,000 units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $3,500,000. The Private Placement Units (and underlying securities) are identical to the Units sold in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 30, 2026, in connection with the IPO, William Sherman was appointed to the board of directors of the Company (the “Board”) effective July 31, 2026. Effective July 31, 2026, Mr. Sherman was appointed to the Board’s Audit Committee, also serving as interim chair of the Audit Committee. Mr. Sherman was also appointed to the Board’s Compensation Committee, serving as chair of the Compensation Committee.

On July 30, 2026, the Company entered into indemnification agreements with each of the directors and executive officers, which require the Company to indemnify each of them to the fullest extent permitted by applicable law and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified. The foregoing summary of the indemnification agreements does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the form of indemnification agreement, which is filed as Exhibit 10.6 to this Current Report on Form 8-K and incorporated herein by reference.

Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.

On July 30, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on July 30, 2026. The terms of the Amended and Restated Memorandum and Articles of Association are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Amended and Restated Memorandum and Articles of Association is attached as Exhibit 3.1 hereto and incorporated herein by reference.

Item 8.01. Other Events.

A total of $414,000,000, comprised of $411,000,000 of the net proceeds from the IPO (which amount includes up to $15,490,000 of the underwriter’s deferred discount) and $1,500,000 of the proceeds of the sale of the Private Placement Units, was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its taxes, to fund its working capital requirements (subject to an annual limit of $1,000,000), and for winding up and dissolution expenses, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 24 months from the closing of the IPO (or 27 months from the closing of the IPO if the Company has executed a letter of intent, agreement in principle or definitive agreement for an initial business combination within 24 months from the closing of the IPO), subject to applicable law, and (iii) the redemption of the Company’s public shares properly submitted in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association to modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it has not consummated an initial business combination within 24 months from the closing of the IPO (or 27 months from the closing of the IPO if the Company has executed a letter of intent, agreement in principle or definitive agreement for an initial business combination within 24 months from the closing of the IPO) or with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity.

On July 30, 2026, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

On August 3 2026, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are being filed herewith:

Exhibit No.		Description

1.1		Underwriting Agreement, dated July 30, 2026, by and between the Company and Citigroup Global Markets Inc., as the underwriter.

3.1		Amended and Restated Memorandum and Articles of Association of the Company.

4.1		Public Warrant Agreement, dated July 30, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent.

4.2		Private Warrant Agreement, dated July 30, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent.

10.1		Investment Management Trust Agreement, dated July 30, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee.

10.2		Registration Rights Agreement, dated July 30, 2026, by and among the Company and certain security holders.

10.3		Private Placement Units Purchase Agreement, dated July 30, 2026, by and between the Company and the Sponsor.

10.4		Letter Agreement, dated July 30, 2026, by and among the Company, its officers, directors, and the Sponsor.

10.5		Administrative Support Agreement, dated July 30, 2026, by and between the Company and an affiliate of the Sponsor.

10.6		Form of Indemnification Agreement.

99.1		Press Release, dated July 30, 2026.

99.2		Press Release, dated August 3, 2026.

104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CHURCHILL CAPITAL CORP XIII

	By:	/s/ Jay Taragin
		Name:	Jay Taragin
		Title:	Chief Financial Officer
Dated: August 3, 2026

Exhibit 99.1

Churchill Capital Corp XIII Announces the Pricing of Upsized $360 Million Initial Public Offering

NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- Churchill Capital Corp XIII (the “Company”) announced the pricing of its upsized initial public offering of 36,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) under the symbol “XIIIU” commencing today. Each unit consists of one Class A ordinary share of the Company and one-tenth of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the Company expects that the Class A ordinary shares and warrants will be listed on Nasdaq under the symbols “XIII” and “XIIIW,” respectively. The offering is expected to close on August 3, 2026, subject to customary closing conditions.

Churchill Capital Corp XIII was founded by Michael Klein, who is also the founder and managing partner of M. Klein and Company, LLC. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It may pursue an initial business combination target in any business or industry.

Citigroup is acting as sole book-running manager for the offering. The Company has granted the underwriter a 45-day option to purchase up to an additional 5,400,000 units at the initial public offering price to cover over-allotments, if any.

The offering is being made only by means of a prospectus, copies of which may be obtained from Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel: 800-831-9146), or by accessing the U.S. Securities and Exchange Commission’s (the “SEC”) website at www.sec.gov.

A registration statement relating to these securities has been declared effective by the SEC. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Company Contact:

Churchill Capital Corp XIII
info@churchillcapitalcorp.com
212-380-7500

Exhibit 99.2

Churchill Capital Corp XIII Completes Upsized $414 Million Initial Public Offering

NEW YORK, NY, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Churchill Capital Corp XIII (the “Company”) announced today the closing of its upsized initial public offering of 41,400,000 units, which includes 5,400,000 units issued pursuant to the exercise by the underwriter of its over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $414,000,000.

The Company’s units began trading on July 31, 2026 on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “XIIIU.” Each unit consists of one Class A ordinary share of the Company and one-tenth of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “XIII” and “XIIIW,” respectively.

Of the proceeds received from the consummation of the initial public offering (as well as the exercise of the over-allotment option) and a simultaneous private placement of units, $414,000,000 (or $10.00 per unit sold in the public offering) was placed in trust.

The Company was founded by Michael Klein, who is also the founder and managing partner of M. Klein and Company, LLC. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It may pursue an initial business combination target in any business or industry.

Citigroup acted as sole book-running manager for the offering.

The offering was made by means of a prospectus. Copies of the prospectus may be obtained from Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel: 800-831-9146), or by accessing the SEC’s website at www.sec.gov.

Registration statements relating to the securities were declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on July 30, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute “forward-looking statements,” including with respect to the anticipated use of the net proceeds thereof. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Company Contact:

Churchill Capital Corp XIII
info@churchillcapitalcorp.com
212-380-7500

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

16 documents

Churchill Capital XIII completes $414M SPAC IPO

Rhea-AI Filing Summary

Positive

Negative

Insights

8-K Event Classification

Key Figures

Key Terms

FAQ

What did Churchill Capital Corp XIII (XIIIU) raise in its IPO?

How are the Churchill Capital Corp XIII (XIIIU) IPO funds held?

What are the terms of Churchill Capital Corp XIII (XIIIU) units and warrants?

What private placement did Churchill Capital Corp XIII (XIIIU) complete?

How long does Churchill Capital Corp XIII (XIIIU) have to complete a business combination?

Who joined the Churchill Capital Corp XIII (XIIIU) board after the IPO?

Filing Exhibits & Attachments

Press Releases

Agreements & Contracts

Other Documents

Keep reading

Trending in the feed